Letter to the Editor Regarding ‘Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)’
本文未提供摘要,请点击“查看全文”查看完整内容。